Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study
2011 ◽
Vol 33
(11)
◽
pp. 1798-1808
◽
Keyword(s):
2010 ◽
Vol 27
(10)
◽
pp. 1168-1173
◽
Keyword(s):
2014 ◽
Vol 36
(2)
◽
pp. 255-263
◽
Keyword(s):
2018 ◽
Vol 38
(11)
◽
pp. 1001-1009
◽
Keyword(s):
2007 ◽
Vol 119
(1)
◽
pp. S143
Keyword(s):